In vivo imaging of endogenous enzyme activities using luminescent 1,2-dioxetane compounds by unknown
RESEARCH Open Access
In vivo imaging of endogenous enzyme
activities using luminescent 1,2-dioxetane
compounds
Jen-Chieh Tseng1,3* and Andrew L. Kung2
Abstract
Background: Here we present a non-invasive imaging method for visualizing endogenous enzyme activities in living
animals. This optical imaging method is based on an energy transfer principle termed chemically initiated electron
exchange luminescence (CIEEL). The light energy is provided by enzymatic activation of metastable 1,2-dioxetane
substrates, whose protective groups are removed by hydrolytic enzymes such as β-galactosidase and alkaline phosphatase.
In the presence of a nearby fluorescent recipient, the chemical energy within the activated substrate is then transferred
via formation of a charge-transfer complex with the fluorophore, a mechanism closely related to glow stick chemistry.
Results: Efficient CIEEL energy transfer requires close proximity between the trigger enzyme and the fluorescent recipient.
Using cells stained with fluorescent dialkylcarbocyanines as the energy recipients, we demonstrated CIEEL imaging of
cellular β-galactosidase or alkaline phosphatase activity. In living animals, we used a similar approach to non-invasively
image alkaline phosphatase activity in the peritoneal cavity.
Conclusions: In this report, we provide proof-of-concept for CIEEL imaging of in vivo enzymatic activity. In addition, we
demonstrate the use of CIEEL energy transfer for visualizing elevated alkaline phosphatase activity associated with tissue
inflammation in living animals.
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Background
Non-invasive optical imaging of small laboratory animals
has been an important tool for biomedical research in pre-
clinical settings. Light signals are typically generated within
the body using fluorescent or luminescent methods. Fluor-
escence imaging methods use external excitation as the
energy source for signal generation [1]. In order to achieve
deep tissue penetration, several near-infrared (NIR) fluor-
escent molecules and nanoparticles have been developed
for in vivo imaging applications. Many of these probes
have been conjugated with targeting moieties, such as anti-
bodies and protein ligands, for specific targeting and deliv-
ery [1]. In addition, since many fluorescent agents change
their optical properties in response to bio-physiological
changes, such as pH, membrane potential and oxidative
stress, fluorescence imaging is versatile and allows for
development of a broad range of probes as reporters for
different biological applications [2]. Nevertheless, fluores-
cent methods in general have low signal-to-noise (S/N)
ratios due to potential interference of excessive excitation
photons. Furthermore, successful fluorescence imaging re-
lies on the pharmacokinetic properties of the fluorescent
agents to establish contrast in the target tissues [3]. On the
other hand, luminescence imaging uses chemical sub-
strates as the energy sources [4, 5]. Without the interfer-
ence of external light, luminescence imaging is in general
more sensitive and has better S/N ratios than fluorescent
methods [6]. For example, bioluminescence imaging (BLI)
has been widely used for in vivo imaging in small labora-
tory animals [4]. BLI generates light signals using the lucif-
erases found in light-producing organisms. Luciferases are
unique enzymes capable of light production by catalyzing
oxidation of their specific luciferin substrates. In particular,
firefly luciferase is commonly used for BLI and its expres-
sion can be ectopically introduced into mammalian cells
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for imaging purposes. In the presence of its specific sub-
strate D-luciferin, BLI is a measure of cell number and mi-
gration in living animals [4]. However, compared with
fluorescence imaging, BLI is less flexible since it requires
genetic modifications of the target cells or tissues for lucif-
erase expression and depends on the use of compatible lu-
ciferin substrates for light production [4].
We have previously demonstrated a hybrid optical
imaging method that combines the advantages of both
luminescence and fluorescence imaging [7]. The method
is based on an energy transfer mechanism termed chem-
ically initiated electron exchange luminescence (CIEEL)
[8]. Using a chemiluminescent compound MCLA as the
energy source and a mitochondria-targeting JC-1 fluor-
escent dye as the chemical energy recipient, we were
able to visualize endogenous reactive oxygen species
(ROS) production in living animals [7]. MCLA, or 6-
(4-methoxyphenyl)-2-methyl-3,7-dihydroimidazo[1,2-a]
pyrazin-3-one hydrochloride, is a Cypridina luciferin ana-
log that can be activated by ROS to form a high-energy
1,2-dioxetane derivative [9, 10]. Importantly, the chemical
energy stored within the high-energy intermediate can be
transferred via formation of a charge-exchange complex
with the nearby fluorescent recipient, which then emits
light according to the fluorophore’s emission property [7].
This energy transfer mechanism is very similar to the
glow stick chemistry where the peroxalate bis-2,4,6-
(trichlorophenyl)oxalate (TCPO) is used as the energy
source to generate high-energy 1,2-dioxetane derivatives
[11]. Since mammalian mitochondria constantly produce
ROS as byproducts of oxidative phosphorylation, targeting
the organelle with a mitochondria-targeting JC-1 fluores-
cent dye enables visualization of endogenous ROS produc-
tion in vivo [7]. Beside mitochondria, phagocytes produce
high levels of ROS in the phagosomes during active phago-
cytosis of invading bacteria [12], a phenomenon that can
also be imaged by CIEEL energy transfer using MCLA and
a phagosome-targeting fluorescent dye [7].
CIEEL energy transfer mechanism is different from
resonance-based energy transfer mechanisms, such as
bioluminescence resonance energy transfer (BRET) and
chemiluminescence resonance energy transfer (CRET)
[13, 14]. Both BRET and CRET are based on a mechan-
ism similar to the Förster resonance energy transfer
(FRET), in which efficient energy resonance requires
spectral overlap between the donor’s emission spectrum
and the recipient’s absorption spectrum. In other words,
both donor and recipient molecules have to be “in sync”
for efficient energy transfer. In contrast, CIEEL energy
transfer is a Dexter mechanism in which electron ex-
change occurs between the energy donor 1,2-dioxetane
and the fluorescent recipient [8]. This alternative mech-
anism implies direct intermolecular collision between
the donor and recipient molecules, and energy transfer
occurs without spectral requirement for the donor and
recipient. As a result, the CIEEL imaging technique is
capable of generating a variety of emission colors by
using a single high-energy substrate. Glow sticks are
good examples of CIEEL energy transfer luminescence,
which are capable of generating a variety of colors using
a single peroxalate TCPO compound as the energy
source [11, 15]. The color of a glow stick is solely deter-
mined by the recipient fluorescent dye of choice. Thus,
CIEEL is a hybrid imaging technique with the advan-
tages of luminescence and fluorescence imaging. With-
out the use of an external light source, CIEEL has lower
background noise in comparison with the conventional
fluorescence imaging methods. Meanwhile, CIEEL im-
aging is more flexible than bioluminescence imaging as
it can adapt to a greater variety of fluorescent recipients
for different emission colors.
In addition to peroxalate-based compounds, several
1,2-dioxetane chemiluminescent substrates have been
widely used for biochemical detection of enzyme activ-
ities in vitro such as β-galactosidase (Galacton-plus®,
Fig. 1a) and alkaline phosphatase (CSPD®, Fig. 1a) [16].
Upon removal of the protective galactosyl or phosphoryl
group, the negative electrical charge on the phenolate
group triggers an electron transfer event that in turn in-
duces decomposition of the high-energy 1,2-dioxetane
ring (Fig. 1a) [16]. The decomposition would generate
several high-energy intermediates in excited states. One
possibility is generating an excited methyl-benzene carb-
oxylate moiety. The fates of the excited intermediates
would largely depend upon the surrounding environ-
ments. In an aqueous solution, the majority of excited
intermediates are quenched by surrounding water mole-
cules and results in heat release (Fig. 1b) [16]. It is un-
avoidable to have heat release during CIEEL imaging
due to the ubiquitous presence of water in biological
systems. Nevertheless, the extent of water quenching
should not vary considerably among different animal
subjects as water activity tends to be well controlled in
tissues. Reducing water activity by adding macromol-
ecule enhancers, such as polymer micelles, protects
them from water quenching and thus promotes energy
released through the phenolate ring as blue chemilumin-
escence (466 nm, Fig. 1b). However, blue light is not
suitable for in vivo imaging due to its strong absorbance
by hemoglobin. Redder emission can be achieved by
coupling the activated substrate with a nearby recipient
fluorophore. The activated substrate can directly transfer
its chemical energy to the fluorescent dye via intermo-
lecular CIEEL energy transfer (Fig. 1c). Of note, it is
possible to use a near-infrared fluorescent probe as the
energy recipient in order to further enhance tissue
penetration and signal strength. In this study, we exam-
ine the use of 1,2-dioxetane substrates for visualizing
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enzyme activities in biological systems. In particular, we
demonstrate the use of this novel concept for imaging




The human colon cancer HCT116 cells were cultured in
DMEM supplied with 10 % FCS. The cells were stably
transfected with a plasmid pBMN-Z-IN (Addgene Inc.,
Cambridge MA) carrying a LacZ-IRES-Neo cassette for
bacterial β-galactosidase expression. The resulting cells,
HCT116/LacZ were maintained under selection with
G418 at 1 mg/mL. The human multiple myeloma
MM1S cells were maintained in RPMI 1640 medium
with 10 % FCS.
Energy transfer imaging of β-galactosidase activity
For energy transfer imaging of biotin-streptavidin
conjugates, each well contained 300 μL total reaction
in PBS including: 1 μg biotinylated β-galacotidase
(biotin/protein = 2.91, 430 units/mg protein, from E. coli,
Sigma-Aldrich, St. Louis MO), 1 μL of Galacton-Plus con-
centrate (Applied Biosystems, Foster City CA), 0–160
pmol of ovalbumin-Alexa Fluor 647 conjugate (Invitrogen,
Carlsbad CA) or 0–160 pmol of streptavidin-Alexa Fluor
647 conjugate (Invitrogen, Carlsbad CA). Lumines-
cence was imaged using the IVIS Spectrum System
(PerkinElmer, Waltham MA) without any emission filter
(open) for total luminescence output, or individually with
emission filters at 500 or 680 nm. The 500 nm lumines-
cence indicated self-decompostion chemiluminescence
levels and the 680 nm luminescence indicated Alexa-Fluor
647 CIEEL energy transfer signal. Fluorescent images were
also acquired with an excitation filter at 640 nm and an
emission filter at 680 nm to determine the input level of
Alexa Fluor in each well.
For energy transfer imaging of β-galactosidase activity
in cells, we stained the plasma membrane of HCT116/
LacZ cells with dialkylcarboncyanine DiD, DiI, or DiR
Fig. 1 CIEEL energy transfer for imaging enzyme activities. a Chemical structures of 1,2-dioxetane chemiluminescent substrates and their activation
by hydrolytic enzymes. Galacton-plus is a substrate for β-galatosidase, and CSPD is an alkaline phosphatase substrate. The hydrolytic activity of
β-galatosidase or alkaline phosphatase removes the protective group X and results in substrate activation. b In the absence of a recipient fluorescent
dye, the activated substrate self-decomposes and results in blue chemiluminescence emission or heat release due to water quenching. c In the
presence of a fluorescent recipient, the activated substrate can directly transfer its chemical energy via formation of a charge-transfer complex with the
recipient fluorophore
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(Invitrogen, Carlsbad CA). Pellets of 1x107 HCT116/
LacZ cells were resuspended in 2.5 mL of staining solu-
tion and incubate at 37 °C for 15 min. For single-stained
cells, the staining solution contained 0.2 μM of dye in
HBSS. For double-stained cells, the staining solution
contained 0.1 μM of each dye in HBSS. After incubation,
cells were washed with fresh HBSS and resuspended in
1 mL of HBSS. To visualize dialkylcarboncyanine energy
transfer, 100 μL of cell suspension was transferred to a
black 96-well luminescent plate, and 100 μL of HBSS
containing 2 μL of Galacton-Plus concentrate was added
into each well. Images were first acquired with an open
filter and then acquired from 500 nm to 840 nm at
20 nm intervals (1 min, binning =16, f1 for each emis-
sion filter). Spectral unmixing was performed using the
Living Image software (PerkinElmer, Waltham MA). A
composite image was generated where the green pseudo-
color indicated the DiD CIEEL signal and the red pseu-
docolor indicated the DiR CIEEL signal.
MM1S cells were stained with HBSS containing 1 μM
of DiR. After incubation at 37 °C for 15 min, cells were
pelleted and resuspended in fresh HBSS. To generate
DiR energy transfer, 100 μL of DiR-stained MM1S-
LucNeo cell suspension (10 million) was added into
100 μL of HBSS containing 2 μL of CSPD alkaline phos-
phatase substrate (Applied Biosystems) in a black 96-well
plate. Non-stained MM1S-LucNeo cells were included as
negative controls. Cell luminescence emission was scanned
from 500 to 840 nm.
Energy transfer imaging of endogenous phosphatase
activity
All animal procedures and imaging protocols are per-
formed under DFCI institutional IACUC guidelines. Sple-
nocytes were harvested from NCr nude mice (Charles
River Laboratories, Wilmington MA) and were treated
with RBC lysis buffer (Qiagen, Valencia CA). The cells
were then washed with HBSS prior to a 24 h culture
period in RPMI 1640 containing 10 % FCS and 5 mg/mL
of lipopolysaccharide (LPS, from Samonella enterica,
Sigma Aldrich). The cells were collected and then
stained with HBSS containing 1 μM of DiR. To generate
light signal, the DiR-stained splenocytes suspension
(100 μL, 1x107) was transferred into 100 μL of HBSS
containing 2 μL of CSPD alkaline phosphatase substrate
(Applied Biosystems) on a black 96-well plate. Untreated
splenocytes cells were used as negative controls. For in
vivo imaging, NCr nude mice received i.p. injection of
10 mg/kg LPS (Sigma Aldrich) in normal saline. In some
animals, dexamethasone sodium phosphate (10 mg/kg,
American Regent Inc., Shirley NY) was given 1 h prior
to LPS challenge. 24 h later, the animal received an i.p.
injection of 400 μL solution containing 50 % CSPD,
50 % reaction diluent, and 0.25 mg/mL DiR, prior to
imaging. Cell and animal luminescence were scanned
from 520 to 800 nm in 40 nm steps.
Results
Enzyme-mediated energy transfer imaging using a
1,2-dioxetane substrate
Galacton-plus is a 1,2-dioxetane substrate that has been
commonly used in a variety of chemiluminescent assays
for detecting β-galactosidase activity in aqueous samples.
In order to demonstrate intermolecular CIEEL energy
transfer in vitro, we took advantage of biotin-
streptavidin interaction to bring together both the bac-
terial β-galactosidase enzyme and the Alexa Fluor 647
fluorophore (Fig. 2). The biotinylated β-galactosidase
served as the trigger enzyme and the streptavidin-
conjugated Alexa Fluor 647 functioned as the energy
recipient. We reasoned that the biotin-conjugated β-
galactosidase would catalyze the 1,2-dioxetane Galacton-
plus substrate to release high-energy intermediates. As
the biotin-streptavidin interaction brought both moieties
in close proximity, the streptavidin-conjugated Alexa
Fluor 647 could capture the chemical energy within the
intermediates and emit a red luminescence. It is known
that resonance energy transfer requires sufficient spec-
tral overlap between the donor’s emission and the reci-
pient's excitation spectra. However, since the Galacton-
plus is a blue chemiluminescence substrate, there is vir-
tually no spectral overlap between Galacton-plus’ blue
emission and Alexa Fluor’s red excitation spectra
(Fig. 2a).
Increasing levels of streptavidin-Alexa Fluor 647 fluor-
escent conjugates were added into wells that contain the
biotinylated β-galactosidase and the Galacton-plus sub-
strate (Fig. 2b). After adding Glacton-plus, we used two
emission filters for luminescence imaging. The blue
500 nm emission filter was used to determine the con-
ventional blue chemiluminescence of Galacton-plus, and
the red 680 nm filter was used to determine the levels of
energy transfer to Alexa Fluor 647. Ovalbumin-Alexa
Fluor 647 conjugate that cannot bind to biotin was used
as a control. Since equal amounts of β-galactosidase
were used in all wells, the blue luminescence corre-
sponding to self-decomposition (500 nm) was not
affected by increasing levels of either fluorescent conju-
gates. Nevertheless, we observed higher levels of total lu-
minescence (open filter) in wells containing fluorescent
streptavidin conjugates (Fig. 2b). In contrast, the ovalbu-
min fluorescent conjugate control did not substantially
enhance the total emission output. Also, we observed
that the specific binding between streptavidin-Alexa
Fluor 647 and the biotinylated β-galactosidase signifi-
cantly enhanced the CIEEL energy transfer at 680 nm
(Fig. 2c). Interestingly, this finding suggests that, after
enzyme-mediated substrate activation, a portion of the
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chemical energy results in wasteful heat release due to
water quenching. However, in the presence of nearby
Alexa Fluor 647, the lost chemical energy can be
recaptured and converted it to CIEEL energy transfer
luminescence (680 nm), which in turn increases the
total luminescence output. Since there is minimal
spectral overlap between Galacton-plus emission and
Alexa Fluor 647 absorption, the observed red 680 nm
luminescence is not likely due to a resonance-based
energy transfer between the activated substrate and
the dye, but rather mediated by the charge-transfer
complex mechanism that is similar to the glow stick
chemistry.
CIEEL energy transfer imaging of enzyme activities
in cells
To further test if the resonance mechanism plays a role
in the intermolecular CIEEL energy transfer, we took
advantage of three closely related long-chain dialkylcar-
bocyanines, DiI [DiIC18(3)], DiD [DiIC18(5)] and DiR
[DiIC18(7)], as the fluorescent recipients (Fig. 3a) [17].
These lipophilic fluorophores have similar structures and
only show strong fluorescence when bound to plasma
membrane [17]. Depending on the number of ethelenyl
(−HC =CH−) groups in the linker between the two car-
bocyanines, their emission fluorescent spectra range
from visible yellow-green to the NIR region (Fig. 3a). DiI
Fig. 2 CIEEL energy transfer requires close proximity of the energy source and the recipient fluorophore. a The absorption/emission spectra of
Alexa Fluor 647 (red), and the chemiluminescence emission range of Galacton-plus (blue shaded region). b Each well contained equal amounts
of biotinylated β-galactosidase for Galacton-plus activation. Increasing levels of streptavidin- or ovalbumin-conjugated Alexa Fluor 647 (0–160 pmol)
were added into the wells. The total luminescence output of each well was first visualized without an emission filter (open). The plate was then imaged
at 500 nm (self-decomposition) or 680 nm (CIEEL energy transfer). The levels of Alexa Fluor 647 were determined by a fluorescence imaging using an
Ex 640/Em 680 nm filter set. c Quantitative representation of the CIEEL energy transfer at 680 nm. Error bar = SEM
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has the shortest 3-carbon linker and a yellow-green
spectrum (λex/λem = 549/565 nm). DiD has a 5-carbon
linker and a red fluorescent spectrum (λex/λem = 644/
663 nm). DiR has the longest 7-carbon linker and a NIR
spectrum (λex/λem = 748/780 nm). Of note, among all
three dialkylcarboncyanines, only DiI has an excitation
spectrum overlapping with the blue emission spectrum
of Galacton-plus. DiD and DiR have no appreciable spec-
tral overlap for resonance energy transfer. Thus, if the
resonance-based mechanism is the major contributor to
the observed energy transfer light production, we would
expect DiI to demonstrate the highest energy transfer ef-
ficiency and DiR should be the least efficient.
To test this hypothesis, we used intact HCT116/LacZ
human colon cancer cells that stably express bacterial
β-galactosidase (LacZ) for Galacton-plus activation.
The cells were stained with single (DiI, DiD, or DiR)
or double (DiD + DiR) dialkylcarboncyanines prior to
adding Galacton-plus for light production (Fig. 3b,
no filter). The DiD + DiR double-stained cells contained
half fluorescence strength for each dye in comparison
with the corresponding single-stained ones. We then
performed step-wise sequential acquiring from 500 to
840 nm to determine the emission profiles (20 nm/step,
Fig. 3b, right panels). Unstained control cells showed
no luminescent emission (no filter), indicating that most
Fig. 3 CIEEL energy transfer imaging of enzyme activities in cells. a Chemical structures and optical properties of three membrane-targeting fluorescent
dialkylcarboncyanines, DiI, DiD, and DiR. The blue shaded region indicates the self-decomposition light emission of Galacton-plus. b Human HCT116/LacZ
colon cancer cells were single-stained with DiI, DiD, DIR or double-stained with both DiD and DiR prior to CIEEL imaging with Glalacton-plus. The cells
were stably transfected with a LacZ construct for bacterial β-galactosidase expression and Galacton-plus activation. The total luminescence emission was
imaged without an emission filter (open), and then scanned from 500 to 680 nm. Fluorescence imaging was also performed to determine the input
levels of dyes. The DiD + DiR double-stained cells contained half fluorescence intensity for each dye in comparison with the corresponding
single-stained cells. c Quantitative representation of the luminescence emission profiles as in b
Tseng and Kung Journal of Biomedical Science  (2015) 22:45 Page 6 of 11
of enzyme-activated intermediates were subsequently
quenched in the absence of any recipient dye. In contrast,
cells stained with either DiD, DiR or both demonstrated
dye-specific energy transfer signals. Quantitative presen-
tation of the luminescent CIEEL signals showed great
accordance with the theoretical emission spectra of
the DiD and DiR (Fig. 3c). In particular, the DiR-stained
cells showed the highest level of energy transfer lumines-
cence (~200 times higher than DiI), followed by the
DiD-stained cells which showed intermediate energy
transfer (~10 times higher that DiI). The lower DiD
energy transfer signals were not likely due to the differ-
ence in fluorescent extinction coefficient (εfluoro) or
quantum yield (Φ). In fact, both DiD and DiR have
comparable εfluoro ×Φ values. Furthermore, we observed
very low levels of energy transfer to the DiI-stained cells.
Although DiI has the lowest εfluoro ×Φ value compared
with DiD and DiR (55 % reduction), these low values do
not seem to account for the more drastic reduction we
observed in it’s energy transfer capability (~200 fold less
than DiR). These observations are in contrast with the
prediction based on resonance energy transfer mechan-
ism, and therefore suggest that the energy transfer is
not predominantly a resonance-based energy transfer
mechanism. It has been found that the CIEEL intensity
(corrected for quantum yield) decreases as the singlet
excitation energy and the oxidation potential increase
[18]. In addition, we speculate that the molecular size
of fluorophore structures may also be an important
factor since it positively influences the incidence of
intermolecular collision.
By analyzing the emission profile data using the
spectral unmixing function of the Living Image soft-
ware of the IVIS imaging system, we identified two
major emission components (Fig. 4). A composite
image was generated to illustrate the sources of CIEEL
signals (Fig. 4a, composite), where the green indicated
the DiD emission and the red indicated the DiR emission.
The two emission spectra fit nicely with the correspond-
ing emission profiles of DiD and DiR (Fig. 4b). Interest-
ingly, spectral unmixing makes it possible to perform
multi-color energy transfer imaging on the same cells
stained with multiple fluorescent dyes (DiD + DiR,
Fig. 4b), a unique capability which would be useful for
simultaneous investigation of multiple bio-physiological
changes.
Energy transfer imaging of endogenous phosphatase
activity
Since phosphatase activities are commonly present in
many types of mammalian cells, we tested if such en-
dogenous enzyme activities can be used for substrate
activation. Structurally similar to Galacton-plus, CSPD
has been widely used as a chemiluminescent substrate
for detecting alkaline phosphatase activity in a variety of
biological assays (Fig. 1). Hydrolytic phosphatase activity
removes the protective phosphate group of CSPD for
substrate activation. The substrate then generates a
high-energy 1,2-dioxitane intermediate. In order to dem-
onstrate energy capture in cells, we used DiR-stained
MM1S human myeloma cells (Fig. 5). Myeloma cells are
derived from B lymphoid lineage which is known to ex-
press alkaline phosphatase in the plasma membrane
[19]. We observed that the endogenous phosphatase
triggered CSPD activation and resulted in subsequent
energy transfer to DiR. In contrast, without the recipient
fluorophore, the unstained control MM1S cells only
showed self-decomposition luminescence. These results
were consistent with our previous findings where the
Galacton-plus was used as the energy source for β-
galactosidase imaging (Fig. 3).
We then determined if this energy transfer strategy
can be used for imaging endogenous leukocyte alkaline
phosphatase (LAP) activity in mouse splenocytes [20]. In
Fig. 4 Spectral unmixing of the CIEEL signals from different fluorophores. a The emission profile data in Fig. 3b were spectrally unmixed using
the Living Image software. A pseudocolor composite was generated where the red color indicated the relative DiR CIEEL signals and the green
color indicated the relative DiD CIEEL signals. b The unmixed emission profiles of DiD and DiR CIEEL signals
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this set of studies, we used a potent stimulant lipopoly-
saccharide (LPS) to upregulate LAP activity in spleno-
cytes (Fig. 6a). LPS is an important component of
bacterial membrane and is known for its capability to
upregulate LAP activity in neutrophils [20]. Splenocytes
were cultured in the presence of LPS to stimulate intra-
cellular LAP activity. Next day, we used DiR to stain the
cell membrane and then added CSPD to provide chem-
ical energy for imaging. LPS treatment significantly in-
creased the CSPD-DiR energy transfer luminescence in
the range of 720–800 nm (Fig. 6a).
We then tested the in vivo application of the
CSPD-DiR energy transfer for visualizing tissue in-
flammation in living animals. The goal of this set of
studies was to use CSPD-DiR to visualize membrane-
associated alkaline phosphatase (ALP) activity in in-
flamed tissue. This strategy relies on the membrane
targeting capability of DiR to capture CSPD activated
by the membrane-bound ALP during inflammation. In
addition, we chose DiR over DiD for this particular
application since the redder DiR CIEEL emission is
attenuated less by passage through tissue, and is less
subject to feed-associated imaging artifact (the alfalfa
content in common food pellets strongly absorbs light
in DiD’s 640–700 nm fluorescence range). Fig. 6b
demonstrates endogenous phosphatase activity in the
peritoneal cavity in the absence of LPS. Without the
use of DiR as the energy recipient on cell mem-
branes, the endogenous phosphatase activity produces
a luminescence emission profile exclusively in the
blue ~500 nm region. Of note, the blue luminescence
signals could be composed of 1) the freely diffused,
non-membrane bound ALP in the peritoneal fluid, or
2) membrane-associated ALP that can be subject to
upregulation in response to LPS challenge and tissue
inflammation. The use of DiR helps distinguish these
two components as the NIR 720–800 nm emission
represents the specific contribution of membrane-
associated ALP.
In another study, nude mice received intraperitoneal
(i.p.) injection of LPS in order to trigger inflammatory
leukocytes influx into the peritoneal cavity. The day after
LPS treatment, animals were i.p. injected with a mixture
of CSPD and DiR for energy transfer imaging. Compared
with the untreated control mice, we observed higher
CSPD-DiR energy transfer luminescence in the periton-
eal cavity of mice treated with LPS (Fig. 6c). Importantly,
the CSPD-DiR luminescence is specific to tissue inflam-
mation, since pretreatment of the animals with dexa-
methasone, a potent anti-inflammatory drug, prevent
upregulation of membrane-associated ALP activity in-
duced by LPS (Fig. 6d).
Discussion
In this study, we demonstrated intermolecular CIEEL
energy transfer and provide proof-of-principle for
CIEEL-mediated imaging of enzyme activity in living an-
imals. This strategy is a marriage of both luminescence
and fluorescence imaging. By using enzyme-specific
chemiluminescent substrates, CIEEL imaging has low
levels of background noise. But unlike luciferase-based
bioluminescence, this hybrid imaging method takes
advantage of endogenous enzymes and thus elimi-
nates the need for genetic modification and ectopic
luciferase expression. As with other energy transfer
imaging methods such as FRET and BRET, efficient
CIEEL energy transfer requires close proximity be-
tween trigger enzymes (energy source) and fluorescent
Fig. 5 CIEEL energy transfer imaging of endogenous phosphatase activity in cells. Human MM1S myeloma cells were stained with DiR prior to
CIEEL imaging with CSPD, a chemiluminescent 1,2-dioxetane substrate for alkaline phosphatase detection. Unstained cells were used as negative
control. Luminescence emission levels were determined by sequential scanning from 500 to 840 nm. Quantitative representation of the imaging
data showed DiR-mediated energy transfer signals in the 720–840 nm NIR region, a finding consistent with the DiR’s fluorescent emission profile
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recipients (signal read-out) (Fig. 2). Thus CIEEL can also
be coupled with targeting biologics to provide spatial
information.
Aside from the proximity requirement, the energy
transfer mechanisms of CIEEL and BRET are fundamen-
tally different. CIEEL energy transfer is not based on res-
onance but requires direct molecular collision with the
fluorescent recipient [11, 15]. During the collision event,
the high-energy 1,2-dioxetane intermediate forms a
charge-transfer complex and directly transfer its chem-
ical energy to the fluorophore for subsequent light emis-
sion [11, 15]. Thus this feature could bypass the spectral
requirement of BRET, and provides a broader choice for
fluorescent signal read-outs. In a sense, this process is
similar to TCPO-based glow sticks, where the activated
peroxalate form a charge-transfer complex with the fluoro-
phore to commence direct energy transfer [11, 15].
In a typical glow stick, the CIEEL mechanism begins
with oxidation of the energy source, peroxalate substrate
TCPO, to form a metastable 1,2-dioxetanedione, which
then forms a charge-transfer complex with the recipient
fluorophore. Within this transient complex, it is believe
that the energy transfer begins with a single electron
transfer from the fluorophore to 1,2-dioxetannedione.
This extra electron in 1,2-dioxetanedione triggers its de-
composition and elevation of the electron to a higher
energy level. The electron is then transferred back to its
original fluorophore and renders the dye in an excited
state for subsequent light emission. The nature of this
mechanism makes it possible to produce glow sticks
with a great variety of colors, including the use of far-
red and NIR fluorophores for better tissue penetration.
In this study we used enzyme-specific 1,2-dioxetane
substrates as the energy source. Taking advantage of the
spectral unmixing function of IVIS imaging system we
are able to distinguish different CIEEL signals originated
from multiple fluorophores. More importantly, this im-
aging method could enable us to simultaneously monitor
Fig. 6 CIEEL energy transfer imaging of elevated alkaline phosphatase activity during tissue inflammation. a Splenocytes were harvested and
cultured in the presence of LPS, a potent stimulant for inflammatory responses. The cells were then stained with DiR and subjected to CIEEL
imaging with Galacton-plus. Untreated cells were used as negative control. The cells were scanned from 520–800 nm to establish their
luminescence emission profiles. b CIEEL imaging of endogenous phosphatase activity in the peritoneal cavity of normal mice. Animals
received i.p. injection of CSPD in the presence or absence of DiR, and were then subject to sequential luminescence acquisition from 520 to
800 nm. c NCr nude mice were i.p. treated with LPS to induce inflammatory responses in the peritoneal cavity. CIEEL imaging was performed 24 h
later. Untreated control mice were used as imaging control. d Mice were pretreated with dexamethasone, a potent anti-inflammatory drug, and
then challenged by i.p. LPS injection. CSPD-DiR CIEEL imaging was performed 24 h after LPS challenge. Error bar = SEM
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multiple fluorophores by using a chemiluminescent
substrate as the sole energy source. However, the CIEEL
light production efficiency is subject to the photo-
chemical properties of the dye. Besides the quantum
yield, CIEEL efficiency could be affected by the singlet
excitation energy and the oxidation potential of the
fluorescent molecule. It has been found that the CIEEL
intensity (corrected for quantum yield) decreases as the
singlet excitation energy increases [18]. In addition,
there is also a linear relationship between the CIEEL
intensity (corrected quantum yield) and the oxidation
potential of the molecule [18]. These factors may ac-
count for the observed difference among DiI, DiD, and
DiR dyes. As DiI is the bluest dialkylcarboncyanine dye
with the highest singlet excitation energy, it is the less
efficient recipient dye for CIEEL luminescence.
Luciferase-based BRET still requires genetic engineer-
ing to introduce exogenous luciferase as the energy
donor. Since CIEEL imaging directly takes advantage of
endogenous enzymes, there is no need to exogenously
introduce luciferase, either in the form of functional pro-
teins or gene expression constructs. In this and our pre-
vious studies, we have shown the use of CIEEL imaging
to visualize endogenous enzyme activities and ROS pro-
duction in living animals [7]. A nano-particle system
using polymerized peroxalate (since TCPO is rather
unstable in aqueous environments), has been developed
to monitor extracellular hydrogen peroxide and other
reactive oxygen species in vivo [21].
In this study we also demonstrated the use of CIEEL
imaging to monitor increased alkaline phosphatase activ-
ity associated with tissue inflammation. In humans, alka-
line phosphatase is present in all tissues throughout the
entire body. Mammalian alkaline phosphatases (ALP) is
associated with microsomal and plasma membranes in
many tissues. It is anchored to cell membranes by glyco-
phosphatidylinositol (GPI) proteins. Cleavage of these
proteins releases ALP from the membranes and results
in elevated ALP levels in serum. The membrane-bound
feature enhances CIEEL imaging when using membrane-
bound DiR dye. In the peritoneal cavity, there are three
types of alkaline phosphatase (ALP): 1. Free circulating
alkaline phosphatase in the peritoneal fluid (ALPL,
mostly released from the liver, bone or kidney) [22];
2. Intestinal alkaline phosphatase (ALPI) associated
with brush border and basal lateral plasma membrane of
intestinal epithelium [23]; and 3. Leukocyte alkaline
phosphatase (LAP) an isoform of ALPL found on the
plasma membrane of white blood cells [24]. Inflamma-
tion induced by tissue damage and bacterial infection
upregulate ALP activity in the intestines, especially in in-
testine cells [25–27] and infiltrating neutrophil granulo-
cytes [24]. In this study, intraperitoneal delivery of
membrane-targeting DiR and the 1,2-dioxetane ALP
substrate CSPD enabled detection of increased ALP
activity in inflamed gut tissues. The free circulating ALP
in the peritoneal fluid should be a lesser contributor to
the CIEEL energy transfer signals. On the other hand,
membrane-bound ALPI and LAP could provide better
CIEEL efficiency since they are in the proximity to DiR
on the plasma membrane. In particular, ex vivo CIEEL
imaging of splenocytes confirmed elevated LAP activity
in response to an inflammatory stimulus (LPS).
Conclusions
In summary, we demonstrate a novel molecular imaging
technique that has potential for monitoring a wide range
of biological events. It combines the advantage of both
luminescence and fluorescence imaging and has the cap-
ability to perform multi-color imaging on the same sub-
ject. Chemiluminescent substrates have recently gained
attention in biomedical optical imaging. Recent suc-
cesses using polymeric peroxalate nanoparticlels to de-
tect hydrogen peroxide production [21], and using
luminol to detect myeloperoxidase activities in activated
phagocytes [5, 12, 28] have motivated us to explore new
means for luminescent imaging other than conventional
luciferase-based luminescence. We believe this hybrid
imaging technique will join this new trend and have the
potential to become an important research tool with appli-
cations across a broad spectrum of biomedical research.
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